In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug
Rev Esp Quimioter. 2023 Dec 22:ventero22dec2023. doi: 10.37201/req/080.2023. Online ahead of print.NO ABSTRACTPMID:38140799 | DOI:10.37201/req/080.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 23, 2023 Category: Drugs & Pharmacology Authors: C Garc ía-Rivera M Navarro M Parra A S ánchez Bautista I G ómez M P Ventero J C Rodr íguez Source Type: research
Safety of fluoroquinolones
This article reviews the main potentially threatening AEs, the alarms issued by regulatory agencies and therapeutic alternatives.PMID:38140798 | DOI:10.37201/req/143.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 23, 2023 Category: Drugs & Pharmacology Authors: J Barber án A de la Cuerda M I Tejeda Gonz ález A L ópez Aparicio C Monfort Vinuesa A Ramos S ánchez L C Barber án Source Type: research
In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug
Rev Esp Quimioter. 2023 Dec 22:ventero22dec2023. doi: 10.37201/req/080.2023. Online ahead of print.NO ABSTRACTPMID:38140799 | DOI:10.37201/req/080.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 23, 2023 Category: Drugs & Pharmacology Authors: C Garc ía-Rivera M Navarro M Parra A S ánchez Bautista I G ómez M P Ventero J C Rodr íguez Source Type: research
Safety of fluoroquinolones
This article reviews the main potentially threatening AEs, the alarms issued by regulatory agencies and therapeutic alternatives.PMID:38140798 | DOI:10.37201/req/143.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 23, 2023 Category: Drugs & Pharmacology Authors: J Barber án A de la Cuerda M I Tejeda Gonz ález A L ópez Aparicio C Monfort Vinuesa A Ramos S ánchez L C Barber án Source Type: research
In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug
Rev Esp Quimioter. 2023 Dec 22:ventero22dec2023. doi: 10.37201/req/080.2023. Online ahead of print.NO ABSTRACTPMID:38140799 | DOI:10.37201/req/080.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 23, 2023 Category: Drugs & Pharmacology Authors: C Garc ía-Rivera M Navarro M Parra A S ánchez Bautista I G ómez M P Ventero J C Rodr íguez Source Type: research
Safety of fluoroquinolones
This article reviews the main potentially threatening AEs, the alarms issued by regulatory agencies and therapeutic alternatives.PMID:38140798 | DOI:10.37201/req/143.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 23, 2023 Category: Drugs & Pharmacology Authors: J Barber án A de la Cuerda M I Tejeda Gonz ález A L ópez Aparicio C Monfort Vinuesa A Ramos S ánchez L C Barber án Source Type: research
In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug
Rev Esp Quimioter. 2023 Dec 22:ventero22dec2023. doi: 10.37201/req/080.2023. Online ahead of print.NO ABSTRACTPMID:38140799 | DOI:10.37201/req/080.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 23, 2023 Category: Drugs & Pharmacology Authors: C Garc ía-Rivera M Navarro M Parra A S ánchez Bautista I G ómez M P Ventero J C Rodr íguez Source Type: research
Safety of fluoroquinolones
This article reviews the main potentially threatening AEs, the alarms issued by regulatory agencies and therapeutic alternatives.PMID:38140798 | DOI:10.37201/req/143.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 23, 2023 Category: Drugs & Pharmacology Authors: J Barber án A de la Cuerda M I Tejeda Gonz ález A L ópez Aparicio C Monfort Vinuesa A Ramos S ánchez L C Barber án Source Type: research
In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug
Rev Esp Quimioter. 2023 Dec 22:ventero22dec2023. doi: 10.37201/req/080.2023. Online ahead of print.NO ABSTRACTPMID:38140799 | DOI:10.37201/req/080.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 23, 2023 Category: Drugs & Pharmacology Authors: C Garc ía-Rivera M Navarro M Parra A S ánchez Bautista I G ómez M P Ventero J C Rodr íguez Source Type: research
Safety of fluoroquinolones
This article reviews the main potentially threatening AEs, the alarms issued by regulatory agencies and therapeutic alternatives.PMID:38140798 | DOI:10.37201/req/143.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 23, 2023 Category: Drugs & Pharmacology Authors: J Barber án A de la Cuerda M I Tejeda Gonz ález A L ópez Aparicio C Monfort Vinuesa A Ramos S ánchez L C Barber án Source Type: research
In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug
Rev Esp Quimioter. 2023 Dec 22:ventero22dec2023. doi: 10.37201/req/080.2023. Online ahead of print.NO ABSTRACTPMID:38140799 | DOI:10.37201/req/080.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 23, 2023 Category: Drugs & Pharmacology Authors: C Garc ía-Rivera M Navarro M Parra A S ánchez Bautista I G ómez M P Ventero J C Rodr íguez Source Type: research
Dalbavancin as a treatment option for Rothia aeria endocarditis
Rev Esp Quimioter. 2023 Dec 21:vazquez21dec2023. doi: 10.37201/req/051.2023. Online ahead of print.NO ABSTRACTPMID:38131630 | DOI:10.37201/req/051.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 22, 2023 Category: Drugs & Pharmacology Authors: H Toledo A Gimeno J C Alarc ón R Luque-M árquez Source Type: research
Dalbavancin as a treatment option for Rothia aeria endocarditis
Rev Esp Quimioter. 2023 Dec 21:vazquez21dec2023. doi: 10.37201/req/051.2023. Online ahead of print.NO ABSTRACTPMID:38131630 | DOI:10.37201/req/051.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 22, 2023 Category: Drugs & Pharmacology Authors: H Toledo A Gimeno J C Alarc ón R Luque-M árquez Source Type: research
Increase in severe acute respiratory infections in children during the last phase of the COVID-19 pandemic
CONCLUSIONS: During the last year, coinciding with low rates of hospitalization for COVID in Spain, we observed a notable increase in admissions to the PICU for SARI. Probably, the prolonged period of low exposure to pathogens due to the measures adopted during the pandemic might have caused a decrease in population immunity with a rise in severe respiratory infections.PMID:38116940 | DOI:10.37201/req/074.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 20, 2023 Category: Drugs & Pharmacology Authors: L Berm údez-Barrezueta M Brezmes Raposo M Brezmes Raposo M Guti érrez Jimeno E Rodr íguez Merino M Pino-Vel ázquez C Fern ández García-Abril S Rojo Rello J M Eiros Bouza M A Pino-V ázquez Source Type: research
Moraxella spp. bacteremia in children attended in a hospital in southern Spain
Rev Esp Quimioter. 2023 Dec 20:vazquez20dec2023. doi: 10.37201/req/076.2023. Online ahead of print.NO ABSTRACTPMID:38116941 | DOI:10.37201/req/076.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - December 20, 2023 Category: Drugs & Pharmacology Authors: A V ázquez-Pérez E Orti-Morente F Cobo J L Santos-P érez Source Type: research
